{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T02:24:14Z","timestamp":1775183054754,"version":"3.50.1"},"reference-count":22,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100008792","name":"Novartis Pharma","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008792","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004397","name":"Ministry of Public Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004397","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004329","name":"Genzyme","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004329","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004339","name":"Sanofi","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004339","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004337","name":"Roche","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004337","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004326","name":"Bayer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004326","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006010","name":"Bayer Schering","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006010","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006314","name":"Biogen Idec","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006314","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004336","name":"Novartis","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004336","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","msard-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Multiple Sclerosis and Related Disorders"],"published-print":{"date-parts":[[2018,11]]},"DOI":"10.1016\/j.msard.2018.09.009","type":"journal-article","created":{"date-parts":[[2018,9,11]],"date-time":"2018-09-11T16:23:44Z","timestamp":1536683024000},"page":"68-70","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"special_numbering":"C","title":["Herpes simplex virus encephalitis temporally associated with dimethyl fumarate-induced lymphopenia in a multiple sclerosis patient"],"prefix":"10.1016","volume":"26","author":[{"given":"Paola","family":"Perini","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesca","family":"Rinaldi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2313-8462","authenticated-orcid":false,"given":"Marco","family":"Puthenparampil","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michela","family":"Marcon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesco","family":"Perini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paolo","family":"Gallo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.msard.2018.09.009_bib0001","doi-asserted-by":"crossref","first-page":"e401","DOI":"10.1212\/NXI.0000000000000401","article-title":"Impaired T-cell migration to the CNS under fingolimod and dimethyl fumarate","volume":"4","author":"Amandine","year":"2017","journal-title":"Neurol. Neuroimmunol. Neuroinflamm"},{"issue":"9","key":"10.1016\/j.msard.2018.09.009_bib0002","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1111\/jdv.14236","article-title":"Progressive multifocal leukoencephalopathy associated with fumaric acid esters treatment in psoriasis patients","volume":"31","author":"Balak","year":"2017","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"10.1016\/j.msard.2018.09.009_bib0003","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1086\/605498","article-title":"Herpes simplex encephalitis during treatment with tumor necrosis factor-alpha inhibitors","volume":"49","author":"Bradford","year":"2009","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.msard.2018.09.009_bib0004","doi-asserted-by":"crossref","first-page":"152","DOI":"10.3109\/00365548.2013.849816","article-title":"Herpes simplex virus encephalitis during treatment with etanercept","volume":"46","author":"Crusio","year":"2014","journal-title":"Scand. J. Infect. Dis."},{"issue":"July","key":"10.1016\/j.msard.2018.09.009_bib0005","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1186\/s12883-015-0363-8","article-title":"Case report of a patient with progressive multifocal leukoencephalopathy under treatment with dimethyl fumarate","volume":"15","author":"Dammeier","year":"2015","journal-title":"BMC Neurol."},{"key":"10.1016\/j.msard.2018.09.009_bib0006","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1093\/cid\/cit376","article-title":"Central nervous system herpes simplex and varicella zoster virus infections in natalizumab-treated patients","volume":"57","author":"Fine","year":"2013","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.msard.2018.09.009_bib0007","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1212\/CPJ.0000000000000238","article-title":"Characterizing absolute lymphocyte count profiles in dimethyl fumarate-treated patients with MS","volume":"6","author":"Fox","year":"2016","journal-title":"Neurol. Clin. Pract."},{"issue":"7","key":"10.1016\/j.msard.2018.09.009_bib0008","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1177\/1352458517741207","article-title":"Diffuse dermatophytosis occurring on dimethyl fumarate therapy","volume":"24","author":"Greenstein","year":"2018","journal-title":"Mult. Scler."},{"key":"10.1016\/j.msard.2018.09.009_bib0009","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/s11908-017-0568-7","article-title":"Herpes simplex encephalitis: an update","volume":"19","author":"J.W.","year":"2017","journal-title":"Curr. Infect. Dis. Rep."},{"key":"10.1016\/j.msard.2018.09.009_bib0010","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1097\/CCM.0b013e3182374a34","article-title":"Herpes simplex virus encephalitis despite normal cell count in the cerebrospinal fluid","volume":"40","author":"Jakob","year":"2012","journal-title":"Crit. Care Med."},{"key":"10.1016\/j.msard.2018.09.009_bib0011","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1177\/1352458511428082","article-title":"Herpes encephalitis during natalizumab treatment in multiple sclerosis","volume":"18","author":"Kwiatkowski","year":"2012","journal-title":"Mult. Scler."},{"key":"10.1016\/j.msard.2018.09.009_bib0012","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1177\/1352458515608961","article-title":"Dimethyl fumarate selectively reduces memory T cells in multiple sclerosis patients","volume":"22","author":"Longbrake","year":"2016","journal-title":"Mult. Scler."},{"issue":"2","key":"10.1016\/j.msard.2018.09.009_bib0013","doi-asserted-by":"crossref","first-page":"e203","DOI":"10.1212\/NXI.0000000000000203","article-title":"Disseminated zoster with paresis in a multiple sclerosis patient treated with dimethyl fumarate","volume":"3","author":"Ma","year":"2016","journal-title":"Neurol. Neuroimmunol. Neuroinflamm"},{"key":"10.1016\/j.msard.2018.09.009_bib0014","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1007\/s00415-017-8516-x","article-title":"Burden of herpes simplex virus encephalitis in the United States","volume":"264","author":"Modi","year":"2017","journal-title":"J. Neurol."},{"key":"10.1016\/j.msard.2018.09.009_bib0015","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1056\/NEJMc1413724","article-title":"PML in a patient without severe lymphocytopenia receiving dimethyl fumarate","volume":"372","author":"Nieuwkamp","year":"2015","journal-title":"N. Engl. J. Med."},{"issue":"23","key":"10.1016\/j.msard.2018.09.009_bib0016","doi-asserted-by":"crossref","first-page":"2377","DOI":"10.1212\/WNL.0000000000001659","article-title":"Reactivation of herpesvirus under fingolimod: a case of severe herpes simplex encephalitis","volume":"84","author":"Pfender","year":"2015","journal-title":"Neurology"},{"key":"10.1016\/j.msard.2018.09.009_bib0017","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1684\/ejd.2013.2014","article-title":"Immunological changes in psoriasis patients under long-term treatment with fumaric acid esters: risk of Kaposi sarcoma occurrence?","volume":"23","author":"Philipp","year":"2013","journal-title":"Eur. J. Dermatol."},{"issue":"15","key":"10.1016\/j.msard.2018.09.009_bib0018","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1056\/NEJMc1415408","article-title":"PML in a patient with lymphocytopenia treated with dimethyl fumarate","volume":"372","author":"Rosenkranz","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.msard.2018.09.009_bib0019","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.jcv.2013.10.025","article-title":"Acyclovir-resistant herpes simplex encephalitis in a patient treated with anti-tumor necrosis factor-alpha monoclonal antibodies","volume":"59","author":"Schepers","year":"2014","journal-title":"J. Clin. Virol."},{"key":"10.1016\/j.msard.2018.09.009_bib0020","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.msard.2013.02.006","article-title":"Does natalizumab treatment increase the risk of herpes simplex encephalitis in multiple sclerosis? Case and discussion","volume":"2","author":"Sharma","year":"2013","journal-title":"Mult. Scler. Relat. Disord."},{"key":"10.1016\/j.msard.2018.09.009_bib0021","doi-asserted-by":"crossref","first-page":"e76","DOI":"10.1212\/NXI.0000000000000076","article-title":"Reduction of CD81 T lymphocytes in multiple sclerosis patients treated with dimethyl fumarate","volume":"2","author":"Spencer","year":"2015","journal-title":"Neurol. Neuroimmunol. Neuroinflamm"},{"key":"10.1016\/j.msard.2018.09.009_bib0022","doi-asserted-by":"crossref","first-page":"2125","DOI":"10.1212\/WNL.0b013e3182752ceb","article-title":"Atypical manifestations and poor outcome of herpes simplex encephalitis in the immunocompromised","volume":"79","author":"Tan","year":"2012","journal-title":"Neurology"}],"container-title":["Multiple Sclerosis and Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034818303213?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034818303213?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T08:44:01Z","timestamp":1761900241000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211034818303213"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11]]},"references-count":22,"alternative-id":["S2211034818303213"],"URL":"https:\/\/doi.org\/10.1016\/j.msard.2018.09.009","relation":{},"ISSN":["2211-0348"],"issn-type":[{"value":"2211-0348","type":"print"}],"subject":[],"published":{"date-parts":[[2018,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Herpes simplex virus encephalitis temporally associated with dimethyl fumarate-induced lymphopenia in a multiple sclerosis patient","name":"articletitle","label":"Article Title"},{"value":"Multiple Sclerosis and Related Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.msard.2018.09.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}